Adding Kisqali Improves Survival in Younger, Advanced HR+ BC

Options
Moderators
Moderators Member Posts: 25,912

Adding Kisqali Improves Overall Survival in Younger Women With Advanced-Stage Hormone-Receptor-Positive Breast Cancer
June 10, 2019

Results from the MONALEESA-7 trial show that adding Kisqali to hormonal therapy and ovarian suppression significantly improves overall survival in premenopausal women diagnosed with advanced-stage, hormone-receptor-positive, HER2-negative breast cancer. Read more...

Categories